Status:

TERMINATED

Pain Perception of Children and Youth Receiving Non-sedated Botulinum Toxin-A Injections Using the Buzzy®

Lead Sponsor:

Hamilton Health Sciences Corporation

Conditions:

Pain

Eligibility:

All Genders

2-18 years

Phase:

NA

Brief Summary

The use of Botulinum toxin injections (BoNT-A) has become a standard therapy for children and youth who suffer from stiffness of their muscles due to a neurological problem. These injections are given...

Detailed Description

Children and youth who receive hypertonia treatment with non-sedated BoNT-A injection will be invited to participate in this clinical trial. The patients will be randomized to receiving the injection ...

Eligibility Criteria

Inclusion

  • Any child and youth who receives non-sedated Botulinum toxin-A injections and is interested and consenting to using the Buzzy

Exclusion

  • Patients receiving Botulinum Toxin-A injections under sedation
  • Patients younger than 2 years or older than 18 years.

Key Trial Info

Start Date :

December 1 2014

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

August 1 2015

Estimated Enrollment :

23 Patients enrolled

Trial Details

Trial ID

NCT02273284

Start Date

December 1 2014

End Date

August 1 2015

Last Update

March 20 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

McMaster Children's Hospital

Hamilton, Ontario, Canada, L8S 4 K1